Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Schulz

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseO Eberhardt, R V Coelln, S Kugler, et al.
Cell Death and Differentiation|April 16, 1999
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxiaJ B Schulz, M Weller, R T Matthews, et al.
Psychological Medicine|May 20, 2016
Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative dataS Fengler, S Roeske, I Heber, et al.
Neurology|October 21, 2005
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumI G McKeith, D W Dickson, J Lowe, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseO Eberhardt, R V Coelln, S Kugler, et al.
Cell Death and Differentiation|April 16, 1999
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxiaJ B Schulz, M Weller, R T Matthews, et al.
Psychological Medicine|May 20, 2016
Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative dataS Fengler, S Roeske, I Heber, et al.
Neurology|October 21, 2005
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumI G McKeith, D W Dickson, J Lowe, et al.
Pageof 13